Background: Estimating the economic burden of community acquired pneumonia (CAP) managed in ambulatory setting is needed in France since no data are available. Method: A retrospective study (CAPECO) was conducted based on a prospective French study describing patients with suspected CAP managed in primary care (CAPA). The aim of the CAPECO study was to estimate and explain medical costs of a disease episode in CAP patients only followed in ambulatory care and in hospitalised patients. Primary endpoints were the direct medical costs, impact on productivity and costs of incident CAP over one year. Secondary endpoint was to describe predictive factors of costs, hospital admission and stay length. Link to the article
PERSONNE, V., CHEVALIER, J., BUFFEL DU VAURE, C., PARTOUCHE, H., GILBERG, S. and DE POUVOURVILLE, G. (2016). CAPECO: Cost Evaluation of Community Acquired Pneumonia Managed in Primary Care. Vaccine, 19(34), pp. 2275-2280.